SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Natus Medical Inc. - BABY
NEW YORK, March 3, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Natus Medical, Inc. ("Natus" or the "Company") (NASDAQ: BABY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
The investigation concerns whether Natus and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On March 3, 2015, the Company reported material weakness due to aggregation of control deficiencies resulting from a lack of timely risk assessment and monitoring of internal controls. As a result, the Company announced that it would be unable to file its annual report on Form 10-K in a timely manner.
On this news, shares of Natus fell $1.07 per share to $34.26, or more than 3.03%, on March 3, 2015.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
SOURCE Pomerantz LLP
Share this article